A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
The 20 million royalty will be paid to Acura Pharma in late June or early July. Also Pfizer plans to partner with Acura on other opioid drugs using the Aversion TM technology. However my favorite is an OTC product with pseudoephedrine which will be rolled out later this year. Nexafed TM using Impede TM technology. This drug will have the same ingredients as Sudafed TM and brand name.